Based on the modified immune landscape after tweaking CDA expression in cancer cells and comparable tumor growth of sgNT and sgCda Panc02 cancer cells in immunodeficient (nude) mice (Extended Data Fig. 4j,k), we tested the contribution of CD8+ T cells and macrophages after CDA targeting. The gene discussed is CD8A; the disease is cancer.